Observational study finds more pathologic nodal upstaging with more nodes sampled ...

Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that combines Optellum's AI-driven lung cancer risk stratification with ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has received confirmation that its Prospera Lung donor-derived ...

Non-invasive genomic test is designed to help physicians guide next steps for current and former smokers with lung nodules Lung cancer is the leading cause of cancer death worldwide. Lung nodules are ...

Innovations in technology have enabled the creation of point-of-care ultrasound, which allows clinicians to gather images at the first patient assessment, improving care quality by reducing wait times ...

Some experts are calling for universal lung cancer screening.

Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...

Chronic lung disease and socioeconomic factors were independently linked to higher lung cancer risk in never-smokers, highlighting the need for multifactorial risk assessment beyond smoking history.

The California Technology Assessment Forum is requested to review the scientific evidence for the use of low dose spiral computerized tomography (LDCT) as a modality for lung cancer screening. This is ...